CellWell record HH-345247
Excess apolipoprotein B predicts long-term survival in statin-treated CAD irrespective of achieved LDL-C levels: a pooled cohort analysis
Wei Pan; Xiaozhao Lu; Ziwei Zhou; Jin Liu; Shaozhao Zhang; Haozhang Huang; Yibo He; Jingru Deng; Yihang Ling; Xianlin Ruan; Ling Jing; Weipeng Zhang; Shiqun Chen; Xinxue Liao; Jiyan Chen; Xiaodong Zhuang; Yong Liu
2026
In plain language
Excess apoB independently predicts cardiovascular and all-cause mortality in statin-treated CAD patients, even among those with optimal LDL-cholesterol levels.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-345247
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.